Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Urology. 2021 Sep 1;158:57–65. doi: 10.1016/j.urology.2021.07.037

Table 1.

Demographics

Entire Cohort Matched Cohort

Variable No Opioids (N=4565) Opioids (N=6383) Total (n=13143) p-value No Opioids (N=2222) Opioids (N=2222) Standardized Difference
Demographics
Age, years Mean (sd) 57.7 (16.2) 54.3 (15.7) <0.001 56.5 (16.3) 56.3 (15.7) −0.01
Insurance None 102 (2.2%) 157 (2.5%) 305 0.01 50 (2.3%) 43 (1.9%) 0
Private 2578 (56.5%) 3772 (59.1%) 7724 1305 (58.6%) 1316 (59.2%)
Public 1854 (40.6%) 2422 (37.9%) 5045 871 (39.2%) 863 (38.8%)
Charlson comorbidity index 0 3106 (68.0%) 4562 (71.5%) 9318 <0.001 1519 (68.4%) 1537 (69.2%) 0.06
1 751 (16.5%) 1017 (15.9%) 2092 389 (17.5%) 362 (16.3%)
≥2 707 (15.5%) 801 (12.6%) 1729 314 (14.1%) 323 (14.5%)
unknown 1 (0.0%) 3 (0.1%) 4
BMI <25 941 (20.6%) 1238 (19.4%) 2558 0.004 476 (21.4%) 490 (22.1%) 0.03
25-30 1321 (28.9%) 1932 (30.3%) 3850 680 (30.6%) 671 (30.2%)
30-35 977 (21.4%) 1448 (22.7%) 2832 527 (23.7%) 528 (23.8%)
>35 977 (21.4%) 1541 (24.1%) 2930 539 (24.3%) 533 (24.0%)
unknown 349 (7.7%) 224 (3.5%) 973
Sex Male 2092 (45.8%) 3236 (50.7%) 6437 <0.001 1064 (47.9%) 1070 (48.2%) 0.01
Female 2473 (54.2%) 3147 (49.3%) 6706 1158 (52.1%) 1152 (51.9%)
Chronic pain no 4486 (98.3%) 6187 (96.9%) 12830 <0.001 2184 (98.3%) 2188 (98.5%) −0.01
yes 67 (1.5%) 161 (2.5%) 251 38 (1.7%) 34 (1.5%)
unknown 12 (0.3%) 35 (0.6%) 62
Clinical characteristics
Prior ureteral stent no 2558 (56.0%) 4125 (64.6%) 7874 <0.001 1308 (58.9%) 1288 (58.0%) 0.02
yes 1995 (43.7%) 2251 (35.3%) 5229 914 (41.1%) 934 (42.0%)
unknown 12 (0.3%) 7 (0.1%) 40
Urine culture Positive 600 (13.1%) 814 (12.8%) 1606 <0.001 273 (12.3%) 284 (12.8%) 0.04
Negative 3077 (67.4%) 4606 (72.2%) 8997 1596 (71.8%) 1593 (71.7%)
Not performed 888 (19.5%) 963 (15.1%) 2540 353 (15.9%) 345 (15.5%)
Surgical acuity Elective 3712 (81.3%) 5157 (80.8%) 10775 0.04 1836 (82.6%) 1827 (82.2%) −0.01
Urgent/Emergent 696 (15.3%) 1077 (16.9%) 1982 386 (17.4%) 395 (17.8%)
unknown 157 (3.4%) 149 (2.3%) 386
Stone location Renal and ureteral 769 (16.9%) 1049 (16.4%) 2111 0.008 389 (17.5%) 372 (16.7%) 0.06
Renal 980 (21.5%) 1536 (24.1%) 2981 506 (22.8%) 469 (21.1%)
Ureter 2637 (57.8%) 3568 (55.9%) 7530 1327 (59.7%) 1381 (62.2%)
unknown 179 (3.9%) 230 (3.6%) 521
Maximum Stone Diameter, mm mean (std) 7.4 (3.9) 7.4 (3.7) 0.9
Stone size ≤0.5 cm 1506 (33.0%) 2101 (32.9%) 4282 0.9 728 (32.8%) 746 (33.6%) 0.03
>0.5-1cm 2212 (48.5%) 3103 (48.6%) 6367 1134 (51.0%) 1133 (51.0%)
>1cm 671 (14.7%) 965 (15.1%) 1959 360 (16.2%) 343 (15.4%)
unknown 176 (3.9%) 214 (3.4%) 535
Surgical characteristics
Stent during surgery no 1431 (31.4%) 1430 (22.4%) 3514 <0.001 593 (26.%) 593 (26.7%) 0
yes 3131 (68.6%) 4945 (77.5%) 9606 1629 (73.3%) 1629 (73.3%)
unknown 3 (0.1%) 8 (0.1%) 23
Ureteral access sheath no 2995 (65.6%) 3685 (57.7%) 8137 <0.001 1392 (62.7%) 1430 (64.4%) −0.04
yes 1521 (33.3%) 2611 (40.9%) 4812 830 (37.4%) 792 (35.6%)
unknown 49 (1.1%) 87 (1.4%) 294
Intra-operative complications no 4503 (98.6%) 6287 (98.5%) 12949 0.6 2191 (98.6%) 2190 (98.6%) 0
yes 56 (1.2%) 90 (1.4%) 168 31 (1.4%) 32 (1.4%)
unknown 6 (0.1%) 6 (0.1%) 26
Outcomes p-value
Unplanned ED visit within 30 days no 4231 (92.7%) 5736 (89.9%) 12032 <0.001 2047 (92.1%) 2001 (90.1%) 0.015
yes 297 (6.5%) 605 (9.5%) 991 175 (7.9%) 221 (10.0%)
unknown 37 (0.8%) 42 (0.7%) 120
0.103
Readmission no 4391 (96.2% 6100 (95.6%) 12613 0.003 2137 (96.6%) 2119 (95.7%)
yes 131 (2.9%) 253 (4.0%) 419 75 (3.4%) 96 (4.3%)
missing 43 (0.9%) 30 (0.5%) 111